Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study.
Mingot-Castellano ME, García-Donas G, Campos-Álvarez RM, de Mora MCF, Luis-Navarro J, Domínguez-Rodríguez JF, Del Mar Nieto-Hernández M, Sánchez-Bazán I, Yera-Cobo M, Cardesa-Cabrera R, Jiménez-Gonzalo FJ, Caparrós-Miranda I, Entrena-Ureña L, Herrera SJ, Fernández Jiménez D, Díaz-Canales D, Moreno-Carrasco G, Calderón-Cabrera C, Núñez-Vázquez RJ, Pedrote-Amador B, Jiménez Bárcenas R; Grupo Andaluz de Coagulopatías (GACC). Mingot-Castellano ME, et al. Among authors: calderon cabrera c. J Clin Med. 2024 Oct 22;13(21):6294. doi: 10.3390/jcm13216294. J Clin Med. 2024. PMID: 39518433 Free PMC article.
Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study.
Jiménez-Bárcenas R, García-Donas-Gabaldón G, Campos-Álvarez RM, Fernández-Sánchez de Mora MC, Luis-Navarro J, Domínguez-Rodríguez JF, Nieto-Hernández MDM, Sánchez-Bazán I, Yera-Cobo M, Cardesa-Cabrera R, Jiménez-Gonzalo FJ, Ruiz-Cobo MA, Caparrós-Miranda I, Entrena-Ureña L, Fernández Jiménez D, Díaz-Canales D, Moreno-Carrasco G, Calderón-Cabrera C, Núñez-Vázquez RJ, Pedrote-Amador B, Mingot-Castellano ME; Grupo Andaluz de Coagulopatías (GACC). Jiménez-Bárcenas R, et al. Among authors: calderon cabrera c. Br J Haematol. 2024 May;204(5):1977-1985. doi: 10.1111/bjh.19443. Epub 2024 Apr 3. Br J Haematol. 2024. PMID: 38566598
Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial.
Moniche F, Cabezas-Rodriguez JA, Valverde R, Escudero-Martinez I, Lebrato-Hernandez L, Pardo-Galiana B, Ainz L, Medina-Rodriguez M, de la Torre J, Escamilla-Gomez V, Ortega-Quintanilla J, Zapata-Arriaza E, de Albóniga-Chindurza A, Mancha F, Gamero MA, Perez S, Espinosa-Rosso R, Forero-Diaz L, Moya M, Piñero P, Calderón-Cabrera C, Nogueras S, Jimenez R, Martin V, Delgado F, Ochoa-Sepúlveda JJ, Quijano B, Mata R, Santos-González M, Carmona-Sanchez G, Herrera C, Gonzalez A, Montaner J. Moniche F, et al. Among authors: calderon cabrera c. Lancet Neurol. 2023 Feb;22(2):137-146. doi: 10.1016/S1474-4422(22)00526-9. Lancet Neurol. 2023. PMID: 36681446 Clinical Trial.
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib.
Rodríguez-Gil A, Escamilla-Gómez V, Nufer M, Andújar-Sánchez F, Lopes-Ramos T, Bejarano-García JA, García-Guerrero E, Calderón-Cabrera C, Caballero-Velázquez T, García-Calderón CB, Hernández-Díaz P, Reguera-Ortega JL, Rodríguez-Torres N, Martínez-Cibrián N, Rodríguez-Barbosa JI, Villadiego J, Pérez-Simón JA. Rodríguez-Gil A, et al. Among authors: calderon cabrera c. Sci Rep. 2022 May 19;12(1):8348. doi: 10.1038/s41598-022-12407-x. Sci Rep. 2022. PMID: 35589917 Free PMC article.
Circulating microRNA after autologous bone marrow mononuclear cell (BM-MNC) injection in patients with ischemic stroke.
Mancha F, Escudero-Martinez I, Zapata-Arriaza E, Vega-Salvatierra A, Cabezas JA, Lebrato L, Pardo B, De-La-Torre J, Zapata M, Escamilla V, Calderón-Cabrera C, Martín-Sánchez J, Valverde R, Aguera-Morales E, Herrera I, Delgado F, Gamero MÁ, Pérez-Sánchez S, Moya M, Espinosa R, Ortega-Quintanilla J, Gutierrez-Jarrin I, González-García A, Montaner J, Moniche F. Mancha F, et al. Among authors: calderon cabrera c. J Investig Med. 2020 Mar;68(3):807-810. doi: 10.1136/jim-2019-001161. Epub 2019 Dec 17. J Investig Med. 2020. PMID: 31852749 Clinical Trial.
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
Escamilla Gómez V, García-Gutiérrez V, López Corral L, García Cadenas I, Pérez Martínez A, Márquez Malaver FJ, Caballero-Velázquez T, González Sierra PA, Viguria Alegría MC, Parra Salinas IM, Calderón Cabrera C, González Vicent M, Rodríguez Torres N, Parody Porras R, Ferra Coll C, Orti G, Valcárcel Ferreiras D, De la Cámara LLanzá R, Molés P, Velázquez-Kennedy K, João Mende M, Caballero Barrigón D, Pérez E, Martino Bofarull R, Saavedra Gerosa S, Sierra J, Poch M, Zudaire Ripa MT, Díaz Pérez MA, Molina Angulo B, Sánchez Ortega I, Sanz Caballer J, Montoro Gómez J, Espigado Tocino I, Pérez-Simón JA; Grupo Español de Trasplante Hematopoyético (GETH). Escamilla Gómez V, et al. Among authors: calderon cabrera c. Bone Marrow Transplant. 2020 Mar;55(3):641-648. doi: 10.1038/s41409-019-0731-x. Epub 2019 Nov 7. Bone Marrow Transplant. 2020. PMID: 31700138 Free PMC article.
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation.
Caballero-Velázquez T, Calderón-Cabrera C, López-Corral L, Puig N, Marquez-Malaver F, Pérez-López E, García-Calderón C, Rosso-Fernández CM, Caballero Barrigón D, Martín J, Mateos MV, San Miguel J, Pérez-Simón JA; European Myeloma Network. Caballero-Velázquez T, et al. Among authors: calderon cabrera c. Bone Marrow Transplant. 2020 Feb;55(2):419-430. doi: 10.1038/s41409-019-0670-6. Epub 2019 Sep 24. Bone Marrow Transplant. 2020. PMID: 31551517 Clinical Trial.
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Caballero JC, Sánchez Barba M, Hernández Sánchez JM, Such E, Janusz K, Sanz G, Cabrero M, Chillón C, Cervera J, Hurtado AM, Jerez A, Calderón Cabrera C, Valcárcel D, Lumbreras E, Abáigar M, López Cadenas F, Hernández Rivas JM, Del Cañizo MC, Díez Campelo M. Caballero JC, et al. Among authors: calderon cabrera c. Ann Hematol. 2019 Sep;98(9):2151-2162. doi: 10.1007/s00277-019-03751-6. Epub 2019 Jul 16. Ann Hematol. 2019. PMID: 31312927
18F-FDG PET/CT for extramedullary relapse of acute leukemia of ambiguous lineage.
de Bonilla Damiá Á, Fernández López R, Acevedo Báñez I, Calderón Cabrera C, Molinos Quintana A, Borrego Dorado I. de Bonilla Damiá Á, et al. Among authors: calderon cabrera c. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Nov-Dec;38(6):395-396. doi: 10.1016/j.remn.2019.01.009. Epub 2019 Apr 6. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019. PMID: 30967343 English, Spanish. No abstract available.
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH).
García-Cadenas I, Yáñez L, Jarque I, Martino R, Pérez-Simón JA, Valcárcel D, Sanz J, Bermúdez A, Muñoz C, Calderón-Cabrera C, García E, Alonso L, Suárez-Lledó M, González Vicent M, Heras I, Viguria MC, Batlle M, Vázquez L, López J, Solano C; Spanish group of blood and marrow transplantation (GETH). García-Cadenas I, et al. Among authors: calderon cabrera c. Eur J Haematol. 2019 Jun;102(6):465-471. doi: 10.1111/ejh.13226. Epub 2019 Apr 10. Eur J Haematol. 2019. PMID: 30828868
27 results